诺华去铁药地拉罗司在中国上市了吗？

(Deferasirox) is a new type of tridentate iron ion chelator with a high affinity for iron ions. The plasma half-life is about 12 hours. The plasma concentration is relatively stable, ensuring the effectiveness and reliability of iron removal treatment. Moreover, the drug has high lipophilicity, which can ensure the ability to enter cells after oral inhalation. Making the drug into dispersible tablets can improve the problem of poor medication compliance in patients. The method of use is easily accepted by patients and greatly promotes their long-term iron removal treatment.

In a treatment study of 47 children by relevant scholars, the total control rate of the children in the observation group treated with deferasirox was 100.00%, which was higher than the control rate of 85.71 in the control group treated with deferoxamine. The heart and liver T2 data of the children in the observation group after treatment were (39.74±13.96) ms and (8.54±2.96) ms respectively, which was higher than that of the children in the control group (31.49). ±12.62)ms, (3.71±2.04)ms are better. So, has such an effective Novartis iron-removing drug deferasirox been launched in China?

In fact, as early as June 30, 2010, deferasirox had been approved for domestic marketing, and now patients can buy the drugs they need without going abroad. The drug was first approved by the US FDA for marketing in the United States on November 2, 2005. It has been on the market in many European and American countries since 2006. It is suitable for children and adult patients over 2 years old with chronic iron overload caused by blood transfusion. In Europe, it is recommended as first-line therapy for patients over 6 years of age with thalassemia and iron overload.

The Swiss company Novartis hopes that through Novartis' unremitting efforts, it can bring Novartis' advanced pharmaceutical products to Chinese patients and people and ensure people's healthy life. Its production price is relatively cheap, which can reduce certain financial burdens for patients. When purchasing drugs overseas, patients can contact Medical Companion Travel to obtain their specific drug purchasing channels.

Recommended hot articles: /newsDetail/92212.html